Editorial: Dyslipidemia, prevention in the era of personalized medicine?
- PMID: 41755991
- PMCID: PMC12932138
- DOI: 10.3389/fmed.2025.1756918
Editorial: Dyslipidemia, prevention in the era of personalized medicine?
Keywords: apolipoprotein B; atherosclerotic cardiovascular disease; bempedoic acid; dyslipidemia; evidence-based medicine; personalized medicine; proprotein convertase subtilisin/kexin type 9 (PCSK9); sex/gender differences.
Conflict of interest statement
The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous
